Medication-related Osteonecrosis in the Oncology Patient: Inter-professional Communication in Addressing Lesion Stability May Be More Important in Management Than Lesion Resolution
Abstract Patients who are diagnosed with MRONJ while being treated with bone modifying agents(BMAs) at oncologic doses, there is insufficient evidence to support or refute … more